Allergy Testing of Patients Labeled as Penicillin Allergic
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02983630|
Recruitment Status : Completed
First Posted : December 6, 2016
Last Update Posted : January 9, 2018
|Condition or disease||Intervention/treatment|
|Drug Hypersensitivity||Other: Penicillin allergy testing|
|Study Type :||Observational|
|Actual Enrollment :||37 participants|
|Official Title:||Allergy Testing of Primary Care Patients Labeled as Penicillin Allergic|
|Actual Study Start Date :||July 2016|
|Actual Primary Completion Date :||June 30, 2017|
|Actual Study Completion Date :||July 1, 2017|
- Other: Penicillin allergy testing
The standard protocol for testing for penicillin hypersensitivity, including initial skin testing with prick and intradermal evaluation followed by oral challenge if skin testing is negative.
- Allergy testing for penicillin allergy results [ Time Frame: 6 months ]
- Participant satisfaction after allergy testing with follow-up questionnaire [ Time Frame: Within 6 months following testing ]A questionnaire will be provided to participants to review their experience with penicillin allergy testing, whether they will take penicillin in the future and if it is valuable information to be tested. Answers will be yes and no. This information will tell us
- Development of new drug allergies following negative testing questionnaire [ Time Frame: 6 months-2 years ]Follow-up questionnaire will be sent to participants to evaluate whether they have needed any antibiotics and if so, whether they've had any reactions. This will be two yes/no questions to assess the incidence of development of new allergic reaction following negative testing.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02983630
|United States, New York|
|Albany Medical College Allergy, Asthma and Immunology Center|
|Albany, New York, United States, 12203|